Introduction: Elderly individuals with depressive symptoms often show increased susceptibility to mild cognitive impairment (MCI). This study explores the association between depressive symptoms and MCI among older adults in China. Methods: Data from the Shanghai Brain Aging Study (SBAS) were used in this cross-sectional study. MCI was diagnosed through clinical assessments and Montreal Cognitive Assessment (MoCA) scores (≤23). Depressive symptoms were defined as a Geriatric Depression Scale (GDS) score of >10. Binary logistic regression and restricted cubic spline (RCS) analyses were conducted to evaluate the associations between depressive symptoms and MCI, adjusting for potential covariates. Results: The study included 1,506 participants, with 43.6% diagnosed with MCI. Logistic regression analysis revealed a significant association between depressive symptoms and MCI. In the fully adjusted model, depressive symptoms were associated with a 65% higher likelihood of MCI (odds ratio: 1.65, 95% confidence interval: 1.17–2.34). RCS analysis indicated a significant non-linear relationship between depressive symptoms and MCI (p for non-linear = 0.029). Participants with depressive symptoms scored significantly lower on the MoCA subscores for visuospatial and executive function, as well as language abilities (all p < 0.05). Conclusion: Our findings demonstrate a significant association between depressive symptoms and MCI, with depressive symptoms being linked to a higher prevalence of MCI. Early identification and intervention of depressive symptoms, including community screening, psychological therapies, or pharmacological treatments for older adults, may potentially mitigate cognitive decline. However, the cross-sectional design limits causal conclusions, and generalizability may be affected by self-reported depression measures and regional sampling.

Elderly individuals with depressive symptoms tend to have a higher susceptibility to mild cognitive impairment (MCI). This study investigated the association between depressive symptoms and MCI in older adults using data from the Shanghai Brain Aging Study (SBAS). A total of 1,506 participants were included, with 43.6% diagnosed with MCI based on clinical assessments and Montreal Cognitive Assessment (MoCA) scores (≤23). Depressive symptoms were identified using the Geriatric Depression Scale (GDS) with a cutoff score >10. Logistic regression analysis revealed that depressive symptoms were significantly associated with a 65% higher likelihood of MCI (odds ratio: 1.65, 95% confidence interval: 1.17–2.34). Restricted cubic spline analysis further demonstrated a significant non-linear relationship between depressive symptoms and MCI (p for non-linearity <0.001). Participants with depressive symptoms also scored significantly lower on MoCA subscores, particularly in visuospatial and executive function, as well as language (all p < 0.05). However, the cross-sectional design limits causal inferences, and the reliance on self-reported depressive symptoms and the study’s geographical scope may have influenced the results. These findings underscore the importance of early identification and intervention for depressive symptoms, such as community screening, psychological therapies, or pharmacological treatments, to potentially mitigate cognitive decline in older adults.

1.
GBD 2019 Dementia Forecasting Collaborators
.
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
.
Lancet Public Health
.
2022
;
7
(
2
):
e105
25
.
2.
GBD 2019 Diseases and Injuries Collaborators
.
Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
.
Lancet
.
2020
;
396
(
10258
):
1204
22
.
3.
Jia
L
,
Du
Y
,
Chu
L
,
Zhang
Z
,
Li
F
,
Lyu
D
, et al
.
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
.
Lancet Public Health
.
2020
;
5
(
12
):
e661
71
.
4.
Langa
KM
,
Levine
DA
.
The diagnosis and management of mild cognitive impairment: a clinical review
.
JAMA
.
2014
;
312
(
23
):
2551
61
.
5.
de Bruijn
RFAG
,
Akoudad
S
,
Cremers
LG
,
Hofman
A
,
Niessen
WJ
,
van der Lugt
A
, et al
.
Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study
.
J Alzheimers Dis
.
2014
;
42
(
Suppl 3
):
S239
49
.
6.
Manly
JJ
,
Tang
MX
,
Schupf
N
,
Stern
Y
,
Vonsattel
JP
,
Mayeux
R
.
Frequency and course of mild cognitive impairment in a multiethnic community
.
Ann Neurol
.
2008
;
63
(
4
):
494
506
.
7.
Mitchell
AJ
,
Shiri-Feshki
M
.
Temporal trends in the long term risk of progression of mild cognitive impairment: a pooled analysis
.
J Neurol Neurosurg Psychiatry
.
2008
;
79
(
12
):
1386
91
.
8.
Byers
AL
,
Yaffe
K
,
Covinsky
KE
,
Friedman
MB
,
Bruce
ML
.
High occurrence of mood and anxiety disorders among older adults: the National Comorbidity Survey Replication
.
Arch Gen Psychiatry
.
2010
;
67
(
5
):
489
96
.
9.
Richard
E
,
Reitz
C
,
Honig
LH
,
Schupf
N
,
Tang
MX
,
Manly
JJ
, et al
.
Late-life depression, mild cognitive impairment, and dementia
.
JAMA Neurol
.
2013
;
70
(
3
):
374
82
.
10.
Li
JQ
,
Tan
L
,
Wang
HF
,
Tan
MS
,
Tan
L
,
Xu
W
, et al
.
Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies
.
J Neurol Neurosurg Psychiatry
.
2016
;
87
(
5
):
476
84
.
11.
Gallagher
D
,
Kiss
A
,
Lanctot
KL
,
Herrmann
N
.
Toward prevention of mild cognitive impairment in older adults with depression: an observational study of potentially modifiable risk factors
.
J Clin Psychiatry
.
2018
;
80
(
1
):
18m12331
.
12.
Toloraia
K
,
Meyer
A
,
Beltrani
S
,
Fuhr
P
,
Lieb
R
,
Gschwandtner
U
.
Anxiety, depression, and apathy as predictors of cognitive decline in patients with Parkinson’s disease: a three-year follow-up study
.
Front Neurol
.
2022
;
13
:
792830
.
13.
Kwan
RYC
,
Leung
AYM
,
Yee
A
,
Lau
LT
,
Xu
XY
,
Dai
DLK
.
Cognitive frailty and its association with nutrition and depression in community-dwelling older people
.
J Nutr Health Aging
.
2019
;
23
(
10
):
943
8
.
14.
Ismail
Z
,
Elbayoumi
H
,
Fischer
CE
,
Hogan
DB
,
Millikin
CP
,
Schweizer
T
, et al
.
Prevalence of depression in patients with mild cognitive impairment: a systematic review and meta-analysis
.
JAMA Psychiatry
.
2017
;
74
(
1
):
58
67
.
15.
Organization WH [Internet]
.
World Health Organization
[cited 2017 Jan 3]. Available from: https://www.who.int/publications/i/item/depression-global-health-estimates
16.
Pachana
NA
,
Egan
SJ
,
Laidlaw
K
,
Dissanayaka
N
,
Byrne
GJ
,
Brockman
S
, et al
.
Clinical issues in the treatment of anxiety and depression in older adults with Parkinson’s disease
.
Mov Disord
.
2013
;
28
(
14
):
1930
4
.
17.
Shilyansky
C
,
Williams
LM
,
Gyurak
A
,
Harris
A
,
Usherwood
T
,
Etkin
A
.
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study
.
Lancet Psychiatry
.
2016
;
3
(
5
):
425
35
.
18.
Rapaport
MH
,
Clary
C
,
Fayyad
R
,
Endicott
J
.
Quality-of-life impairment in depressive and anxiety disorders
.
Am J Psychiatry
.
2005
;
162
(
6
):
1171
8
.
19.
Tang
T
,
Jiang
J
,
Tang
X
.
Prevalence of depressive symptoms among older adults in mainland China: a systematic review and meta-analysis
.
J Affect Disord
.
2021
;
293
:
379
90
.
20.
Elshaikh
U
,
Sheik
R
,
Saeed
RKM
,
Chivese
T
,
Alsayed Hassan
D
.
Barriers and facilitators of older adults for professional mental health help-seeking: a systematic review
.
BMC Geriatr
.
2023
;
23
(
1
):
516
.
21.
Fang
EF
,
Scheibye-Knudsen
M
,
Jahn
HJ
,
Li
J
,
Ling
L
,
Guo
H
, et al
.
A research agenda for aging in China in the 21st century
.
Ageing Res Rev
.
2015
;
24
(
Pt B
):
197
205
.
22.
GBD 2016 Dementia Collaborators
.
Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol
.
2019
;
18
(
1
):
88
106
.
23.
Lam
B
,
Middleton
LE
,
Masellis
M
,
Stuss
DT
,
Harry
RD
,
Kiss
A
, et al
.
Criterion and convergent validity of the Montreal Cognitive Assessment with screening and standardized neuropsychological testing
.
J Am Geriatr Soc
.
2013
;
61
(
12
):
2181
5
.
24.
Nasreddine
ZS
,
Phillips
NA
,
Bédirian
V
,
Charbonneau
S
,
Whitehead
V
,
Collin
I
, et al
.
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
.
J Am Geriatr Soc
.
2005
;
53
(
4
):
695
9
.
25.
Chen
K-L
,
Xu
Y
,
Chu
A-Q
,
Ding
D
,
Liang
X-N
,
Nasreddine
Z-S
, et al
.
Validation of the Chinese version of Montreal Cognitive Assessment basic for screening mild cognitive impairment
.
J Am Geriatr Soc
.
2016
;
64
(
12
):
e285
90
.
26.
Tan
J-P
,
Li
N
,
Gao
J
,
Wang
L-N
,
Zhao
Y-M
,
Yu
B-C
, et al
.
Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population
.
J Alzheimers Dis
.
2015
;
43
(
4
):
1403
12
.
27.
Carson
N
,
Leach
L
,
Murphy
KJ
.
A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores
.
Int J Geriatr Psychiatry
.
2018
;
33
(
2
):
379
88
.
28.
Petersen
RC
,
Doody
R
,
Kurz
A
,
Mohs
RC
,
Morris
JC
,
Rabins
PV
, et al
.
Current concepts in mild cognitive impairment
.
Arch Neurol
.
2001
;
58
(
12
):
1985
92
.
29.
Wancata
J
,
Alexandrowicz
R
,
Marquart
B
,
Weiss
M
,
Friedrich
F
.
The criterion validity of the Geriatric Depression Scale: a systematic review
.
Acta Psychiatr Scand
.
2006
;
114
(
6
):
398
410
.
30.
Yesavage
JA
,
Brink
TL
,
Rose
TL
,
Lum
O
,
Huang
V
,
Adey
M
, et al
.
Development and validation of a geriatric depression screening scale: a preliminary report
.
J Psychiatr Res
.
1982
;
17
(
1
):
37
49
.
31.
Ran
LS
,
Liu
WH
,
Fang
YY
,
Xu
SB
,
Li
J
,
Luo
X
, et al
.
Alcohol, coffee and tea intake and the risk of cognitive deficits: a dose-response meta-analysis
.
Epidemiol Psychiatr Sci
.
2021
;
30
:
e13
.
32.
Ng
TP
,
Feng
L
,
Nyunt
MS
,
Feng
L
,
Gao
Q
,
Lim
ML
, et al
.
Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: follow-up of the Singapore longitudinal ageing study cohort
.
JAMA Neurol
.
2016
;
73
(
4
):
456
63
.
33.
Knopman
DS
,
Gottesman
RF
,
Sharrett
AR
,
Tapia
AL
,
DavisThomas
S
,
Windham
BG
, et al
.
Midlife vascular risk factors and midlife cognitive status in relation to prevalence of mild cognitive impairment and dementia in later life: the Atherosclerosis Risk in Communities Study
.
Alzheimers Dement
.
2018
;
14
(
11
):
1406
15
.
34.
Rost
NS
,
Brodtmann
A
,
Pase
MP
,
van Veluw
SJ
,
Biffi
A
,
Duering
M
, et al
.
Post-stroke cognitive impairment and dementia
.
Circ Res
.
2022
;
130
(
8
):
1252
71
.
35.
Wang
J
,
Wang
Y
,
Li
S
,
Wu
B
,
Feng
Q
,
Qiu
W
, et al
.
Waist-to-weight index and cognitive impairment: understanding the link through depression mediation in the NHANES
.
J Affect Disord
.
2024
;
365
:
313
20
.
36.
Zhang
J
,
Jia
X
,
Li
Y
,
Zheng
D
,
Guo
X
,
Li
H
, et al
.
The association between serum uric acid and cognitive function among middle-aged and older adults without hyperuricemia: the mediating role of depressive symptoms
.
J Gerontol A Biol Sci Med Sci
.
2024
;
79
(
1
):
glad203
.
37.
Yang
Z
,
Wang
H
,
Edwards
D
,
Ding
C
,
Yan
L
,
Brayne
C
, et al
.
Association of blood lipids, atherosclerosis and statin use with dementia and cognitive impairment after stroke: a systematic review and meta-analysis
.
Ageing Res Rev
.
2020
;
57
:
100962
.
38.
Lyall
LM
,
Cullen
B
,
Lyall
DM
,
Leighton
SP
,
Siebert
S
,
Smith
DJ
, et al
.
The associations between self-reported depression, self-reported chronic inflammatory conditions and cognitive abilities in UK Biobank
.
Eur Psychiatry
.
2019
;
60
:
63
70
.
39.
Chhetri
JK
,
de Souto Barreto
P
,
Cantet
C
,
Cesari
M
,
Coley
N
,
Andrieu
S
, et al
.
Trajectory of the MAPT-PACC-preclinical Alzheimer cognitive composite in the placebo group of a randomized control trial: results from the MAPT study – lessons for further trials
.
J Prev Alzheimers Dis
.
2018
;
5
(
1
):
31
5
.
40.
de Sousa
RD
,
Rodrigues
AM
,
Gregório
MJ
,
Branco
JDC
,
Gouveia
MJ
,
Canhão
H
, et al
.
Anxiety and depression in the Portuguese older adults: prevalence and associated factors
.
Front Med
.
2017
;
4
:
196
.
41.
Bai
W
,
Chen
P
,
Cai
H
,
Zhang
Q
,
Su
Z
,
Cheung
T
, et al
.
Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies
.
Age Ageing
.
2022
;
51
(
8
):
afac173
.
42.
Geda
YE
,
Roberts
RO
,
Mielke
MM
,
Knopman
DS
,
Christianson
TJ
,
Pankratz
VS
, et al
.
Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study
.
Am J Psychiatry
.
2014
;
171
(
5
):
572
81
.
43.
Mehta
K
,
Thandavan
SP
,
Mohebbi
M
,
Pasco
JA
,
Williams
LJ
,
Walder
K
, et al
.
Depression and bone loss as risk factors for cognitive decline: a systematic review and meta-analysis
.
Ageing Res Rev
.
2022
;
76
:
101575
.
44.
Barnes
DE
,
Alexopoulos
GS
,
Lopez
OL
,
Williamson
JD
,
Yaffe
K
.
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study
.
Arch Gen Psychiatry
.
2006
;
63
(
3
):
273
9
.
45.
Ly
M
,
Karim
HT
,
Becker
JT
,
Lopez
OL
,
Anderson
SJ
,
Aizenstein
HJ
, et al
.
Late-life depression and increased risk of dementia: a longitudinal cohort study
.
Transl Psychiatry
.
2021
;
11
(
1
):
147
.
46.
Diniz
BS
,
Butters
MA
,
Albert
SM
,
Dew
MA
,
Reynolds
CF
3rd
.
Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies
.
Br J Psychiatry
.
2013
;
202
(
5
):
329
35
.
47.
Han
F-F
,
Wang
H-X
,
Wu
J-J
,
Yao
W
,
Hao
C-F
,
Pei
J-J
.
Depressive symptoms and cognitive impairment: a 10-year follow-up study from the survey of health, ageing and retirement in Europe
.
Eur Psychiatry
.
2021
;
64
(
1
):
e55
.
48.
Singh-Manoux
A
,
Dugravot
A
,
Fournier
A
,
Abell
J
,
Ebmeier
K
,
Kivimäki
M
, et al
.
Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study
.
JAMA Psychiatry
.
2017
;
74
(
7
):
712
8
.
49.
Scult
MA
,
Paulli
AR
,
Mazure
ES
,
Moffitt
TE
,
Hariri
AR
,
Strauman
TJ
.
The association between cognitive function and subsequent depression: a systematic review and meta-analysis
.
Psychol Med
.
2017
;
47
(
1
):
1
17
.
50.
Mirza
SS
,
Ikram
MA
,
Bos
D
,
Mihaescu
R
,
Hofman
A
,
Tiemeier
H
.
Mild cognitive impairment and risk of depression and anxiety: a population-based study
.
Alzheimers Dement
.
2017
;
13
(
2
):
130
9
.
51.
Bennett
S
,
Thomas
AJ
.
Depression and dementia: cause, consequence or coincidence
.
Maturitas
.
2014
;
79
(
2
):
184
90
.
52.
Huang
YY
,
Gan
YH
,
Yang
L
,
Cheng
W
,
Yu
JT
.
Depression in Alzheimer’s disease: epidemiology, mechanisms, and treatment
.
Biol Psychiatry
.
2024
;
95
(
11
):
992
1005
.
53.
Guo
Y
,
Pai
M
,
Xue
B
,
Lu
W
.
Bidirectional association between depressive symptoms and mild cognitive impairment over 20 years: evidence from the health and retirement study in the United States
.
J Affect Disord
.
2023
;
338
:
449
58
.
54.
Desai
R
,
Charlesworth
GM
,
Brooker
HJ
,
Potts
HWW
,
Corbett
A
,
Aarsland
D
, et al
.
Temporal relationship between depressive symptoms and cognition in mid and late life: a longitudinal cohort study
.
J Am Med Dir Assoc
.
2020
;
21
(
8
):
1108
13
.
55.
Lövheim
H
,
Sandman
PO
,
Karlsson
S
,
Gustafson
Y
.
Behavioral and psychological symptoms of dementia in relation to level of cognitive impairment
.
Int Psychogeriatr
.
2008
;
20
(
4
):
777
89
.
56.
Lima Giacobbo
B
,
Doorduin
J
,
Klein
HC
,
Dierckx
R
,
Bromberg
E
,
de Vries
EFJ
.
Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation
.
Mol Neurobiol
.
2019
;
56
(
5
):
3295
312
.
57.
Hayley
S
,
Hakim
AM
,
Albert
PR
.
Depression, dementia and immune dysregulation
.
Brain
.
2021
;
144
(
3
):
746
60
.
58.
Du
X
,
Pang
TY
.
Is dysregulation of the HPA-axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases
.
Front Psychiatry
.
2015
;
6
:
32
.
59.
Hamilton
JL
,
Brickman
AM
,
Lang
R
,
Byrd
GS
,
Haines
JL
,
Pericak-Vance
MA
, et al
.
Relationship between depressive symptoms and cognition in older, non-demented African Americans
.
J Int Neuropsychol Soc
.
2014
;
20
(
7
):
756
63
.
60.
Yatawara
C
,
Lim
L
,
Chander
R
,
Zhou
J
,
Kandiah
N
.
Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment
.
J Neurol Neurosurg Psychiatry
.
2016
;
87
(
12
):
1375
83
.
61.
Zheng
F
,
Zhong
B
,
Song
X
,
Xie
W
.
Persistent depressive symptoms and cognitive decline in older adults
.
Br J Psychiatry
.
2018
;
213
(
5
):
638
44
.
62.
de Nooij
L
,
Harris
MA
,
Adams
MJ
,
Clarke
TK
,
Shen
X
,
Cox
SR
, et al
.
Cognitive functioning and lifetime major depressive disorder in UK Biobank
.
Eur Psychiatry
.
2020
;
63
(
1
):
e28
.
63.
Pittenger
C
,
Duman
RS
.
Stress, depression, and neuroplasticity: a convergence of mechanisms
.
Neuropsychopharmacology
.
2008
;
33
(
1
):
88
109
.
64.
Walgrave
H
,
Balusu
S
,
Snoeck
S
,
Vanden Eynden
E
,
Craessaerts
K
,
Thrupp
N
, et al
.
Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer’s disease
.
Cell Stem Cell
.
2021
;
28
(
10
):
1805
21.e8
.
65.
Steffens
DC
,
McQuoid
DR
,
Payne
ME
,
Potter
GG
.
Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study
.
Am J Geriatr Psychiatry
.
2011
;
19
(
1
):
4
12
.
66.
Pandey
GN
,
Rizavi
HS
,
Zhang
H
,
Bhaumik
R
,
Ren
X
.
Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide
.
J Psychiatry Neurosci
.
2018
;
43
(
6
):
376
85
.
67.
Misiak
B
,
Beszłej
JA
,
Kotowicz
K
,
Szewczuk-Bogusławska
M
,
Samochowiec
J
,
Kucharska-Mazur
J
, et al
.
Cytokine alterations and cognitive impairment in major depressive disorder: from putative mechanisms to novel treatment targets
.
Prog Neuropsychopharmacol Biol Psychiatry
.
2018
;
80
(
Pt C
):
177
88
.
68.
Myint
AM
,
Kim
YK
.
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis
.
Prog Neuropsychopharmacol Biol Psychiatry
.
2014
;
48
:
304
13
.
69.
Chu
C-L
,
Liang
C-K
,
Chou
M-Y
,
Lin
Y-T
,
Pan
C-C
,
Lu
T
, et al
.
Decreased plasma brain-derived neurotrophic factor levels in institutionalized elderly with depressive disorder
.
J Am Med Dir Assoc
.
2012
;
13
(
5
):
434
7
.
70.
Shimada
H
,
Makizako
H
,
Doi
T
,
Yoshida
D
,
Tsutsumimoto
K
,
Anan
Y
, et al
.
A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive impairment in the elderly
.
Front Aging Neurosci
.
2014
;
6
:
69
.
71.
Edelmann
E
,
Lessmann
V
,
Brigadski
T
.
Pre- and postsynaptic twists in BDNF secretion and action in synaptic plasticity
.
Neuropharmacology
.
2014
;
76
(
Pt C
):
610
27
.
72.
Galts
CPC
,
Bettio
LEB
,
Jewett
DC
,
Yang
CC
,
Brocardo
PS
,
Rodrigues
ALS
, et al
.
Depression in neurodegenerative diseases: common mechanisms and current treatment options
.
Neurosci Biobehav Rev
.
2019
;
102
:
56
84
.
73.
Bueller
JA
,
Aftab
M
,
Sen
S
,
Gomez-Hassan
D
,
Burmeister
M
,
Zubieta
JK
.
BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects
.
Biol Psychiatry
.
2006
;
59
(
9
):
812
5
.
74.
Brunoni
AR
,
Lopes
M
,
Fregni
F
.
A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression
.
Int J Neuropsychopharmacol
.
2008
;
11
(
8
):
1169
80
.
75.
Rosenberg
PB
,
Nowrangi
MA
,
Lyketsos
CG
.
Neuropsychiatric symptoms in Alzheimer’s disease: what might be associated brain circuits
.
Mol Aspects Med
.
2015
;
43–44
:
25
37
.
76.
Drevets
WC
,
Savitz
J
,
Trimble
M
.
The subgenual anterior cingulate cortex in mood disorders
.
CNS Spectr
.
2008
;
13
(
8
):
663
81
.
77.
Zahodne
LB
,
Gongvatana
A
,
Cohen
RA
,
Ott
BR
,
Tremont
G
;
Alzheimer’s Disease Neuroimaging Initiative
.
Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment
.
Am J Geriatr Psychiatry
.
2013
;
21
(
11
):
1098
106
.
You do not currently have access to this content.